Click here for the Ukrainian version.
Click here for the Russian version.

Japanese Society of Medical Oncology (JSMO) just has issued the following statement:

We expect many cancer patients have to receive effective therapy including surgical operation, radiotherapy，and chemotherapy in Ukraine. However, it is currently impossible in Ukraine because the Russian is attacking Ukraine and destroying many medical facilities as well as other buildings and houses. We also know many injured Ukrainians by the Russian attack are not able to receive proper medical care in Ukraine. Moreover, food and drug storage are running out in Ukraine. Thus, medical care is interrupted in Ukraine due to the war. As a global society of medical oncology, the JSMO and its members in the world are in solidarity with Ukrainian patients and citizens during the Russian invasion of their country. We sincerely request the immediate protection and evacuation of the Ukrainian cancer patients and other injured patients to a safe place to receive their appropriate medical treatment.
The progression of medical sciences including medical oncology is based on the global clinical studies and research collaborations of scientists from many countries. We have communicated with many scientists and clinicians including Ukrainian and Russian people to develop new cancer therapies. However, because of the war conducted by Russian leaders, the activities of scientists and clinicians in Ukraine and Russia were completely interrupted. Particularly, the Ukrainian scientists and clinicians ran into life-threatening situations due to the war and cannot participate in clinical studies, research collaboration, medical practices, and exchanges of scientific opinions.
The JSMO condemns Russia’s unjustified invasion of Ukraine, and call for the immediate withdrawal of all Russian troops from Ukraine.

*The summary in this statement was approved at the general meeting of JSMO fiscal year of 2022 held on March 5, 2022.

President, Board of Directors, JSMO
Chikashi Ishioka,Tohoku University
Vice-President, Board of Directors, JSMO
Tetsuji Takayama, Tokushima University
Kenji Tamura, Shimane University


Directors
Yuichi Ando, Nagoya University
Masafumi Ikeda, National Cancer Center Hospital East
Hiroji Iwata, Aichi Cancer Center Hospital
Yuichiro Ohe, National Cancer Center Hospital
Ichiro Kinoshita, Hokkaido University Hospital
Shigehira Saji, Fukushima Medical University
Toshimi Takano, The Cancer Institute Hospital of JFCR
Yukari Tsubata, Shimane University
Takako Nakajima, Kyoto University
Kazuto Nishio, Kindai University
Eishi Baba, Kyushu University
Yasuhiro Fujiwara, Pharmaceuticals and Medical Devices Agency (PMDA)　
Katsuyuki Hotta, Okayama University
Kei Muro, Aichi Cancer Center
Seiji Yano, Kanazawa University
Kazuhito Yamamoto, Aichi Cancer Center
Takayuki Yoshino, National Cancer Center Hospital East

Auditors
Makoto Ueno, Kanagawa Cancer Center
Seiji Niho, Dokkyo Medical University
Kan Yonemori, National Cancer Center Hospital